|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Endocrinology and Metabolism |
1 Department of Pathology & Anatomical Sciences, University of Missouri School of Medicine, Columbia, MO; 2 Department of Statistics, University of Missouri School of Medicine, Columbia, MO; 3 Department of Medicine, Washington University School of Medicine, St. Louis, MO; 4 Centers for Disease Control and Prevention, Division of Environmental Health Laboratory Sciences, Centers for Environmental Health, Chamblee, GA; 5 Benaroya Research Institute, Seattle, WA; 6 University of Washington and VA Medical Center, Seattle, WA; 7 Department of Medicine and GCRC Analytical Core Laboratory, Albert Einstein College of Medicine of Yeshiva University, Bronx, NY.
aAddress correspondence to this author at: Diabetes Diagnostic Laboratory, M767, Department of Pathology & Anatomical Sciences, University of Missouri School of Medicine, 1 Hospital Dr., Columbia, MO 65212. Fax 573-884-8823; e-mail LittleR{at}health.missouri.edu
Background: C-peptide is a marker of insulin secretion in diabetic patients. We assessed within- and between-laboratory imprecision of C-peptide assays and determined whether serum calibrators with values assigned by mass spectrometry could be used to harmonize C-peptide results.
Methods: We sent 40 different serum samples to 15 laboratories, which used 9 different routine C-peptide assay methods. We also sent matched plasma samples to another laboratory for C-peptide analysis with a reference mass spectrometry method. Each laboratory analyzed 8 of these samples in duplicate on each of 4 days to evaluate within- and between-day imprecision. The same 8 samples were also used to normalize the results for the remaining samples to the mass spectrometry reference method.
Results: Within- and between-run CVs ranged from <2% to >10% and from <2% to >18%, respectively. Normalizing the results with serum samples significantly improved the comparability among laboratories and methods. After normalization, the differences among laboratories in mean response were no longer statistically significant (P = 0.24), with least-squares means of 0.93–1.02.
Conclusions: C-peptide results generated by different methods and laboratories do not always agree, especially at higher C-peptide concentrations. Within-laboratory imprecision also varied, with some methods giving much more consistent results than others. These data show that calibrating C-peptide measurement to a reference method can increase comparability between laboratories.
The following articles in journals at HighWire Press have cited this article:
![]() |
P. E.M. De Pauw, I. Vermeulen, O. C. Ubani, I. Truyen, E. M.F. Vekens, F. T. van Genderen, J. W. De Grijse, D. G. Pipeleers, C. Van Schravendijk, and F. K. Gorus Simultaneous Measurement of Plasma Concentrations of Proinsulin and C-Peptide and Their Ratio with a Trefoil-Type Time-Resolved Fluorescence Immunoassay Clin. Chem., December 1, 2008; 54(12): 1990 - 1998. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |